Table 3.
Secondary Study Outcomes
| IANB (n = 32) | IO (n = 32) | P value | |
|---|---|---|---|
| Injection pain, mean (95% CI), mm per HP-VAS | 86.63 (74.30–98.95) | 18.56 (9.94–27.19) | .027 |
| Onset of action, mean (95% CI), minc | 9.54 (8.09–10.99) | 5.26 (4.53–6.00) | <.001 |
| HR increase, mean (95% CI), bpm | 5.56 (5.01–6.11) | 9.06 (7.49–10.63) | <.001 |
| HR recovery time, mean (95% CI), min | 4.92 (4.21–5.64) | 2.53 (1.89–3.16) | <.001 |
| Duration of action, mean (95% CI), minc | 54.92 (51.42–58.42) | 41.62 (39.64–43.62) | <.001 |
Abbreviations: CI, confidence interval; IANB, inferior alveolar nerve block; IO, intraosseous.
c
Data for 24 participants in the IANB group and 31 patients in the IO group.